Biblio

Found 10 results
Filters: Author is Navratilova, Edita  [Clear All Filters]
2023
Ito H, Navratilova E, Vagnerova B, Watanabe M, Kopruszinski C, de Souza LHMoreira, Yue X, Ikegami D, Moutal A, Patwardhan A et al..  2023.  Chronic pain recruits hypothalamic dynorphin/kappa opioid receptor signalling to promote wakefulness and vigilance.. Brain. 146(3):1186-1199.
2022
Watanabe M, Kopruszinski CM, Moutal A, Ikegami D, Khanna R, Chen Y, Ross S, Mackenzie K, Stratton J, Dodick DW et al..  2022.  Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine.. Brain. 145(8):2894-2909.
Kopruszinski CM, Vizin R, Watanabe M, Martinez AL, de Souza LHenrique M, Dodick DW, Porreca F, Navratilova E.  2022.  Exploring the neurobiology of the premonitory phase of migraine preclinically - a role for hypothalamic kappa opioid receptors? J Headache Pain. 23(1):126.
Yakhnitsa V, Ji G, Hein M, Presto P, Griffin Z, Ponomareva O, Navratilova E, Porreca F, Neugebauer V.  2022.  Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain.. Front Pharmacol. 13:903978.
Navratilova E, Oyarzo J, Anderson T, Broide RS, Subramaniam SR, Vazquez-Cintron EJ, Brin MF, Schwedt TJ, Dodick DW, Porreca F.  2022.  Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache.. Cephalalgia. 42(11-12):1194-1206.
Ikegami D, Navratilova E, Yue X, Moutal A, Kopruszinski CM, Khanna R, Patwardhan A, Dodick DW, Porreca F.  2022.  A prolactin-dependent sexually dimorphic mechanism of migraine chronification.. Cephalalgia. 42(3):197-208.
2021
Lançon K, Qu C, Navratilova E, Porreca F, Séguéla P.  2021.  Decreased dopaminergic inhibition of pyramidal neurons in anterior cingulate cortex maintains chronic neuropathic pain.. Cell Rep. 37(9):109933.
2017
Xie JY, De Felice M, Kopruszinski CM, Eyde N, LaVigne J, Remeniuk B, Hernandez P, Yue X, Goshima N, Ossipov M et al..  2017.  Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.. Cephalalgia. 37(8):780-794.
2013
Nair P, Yamamoto T, Largent-Milnes TM, Cowell S, Kulkarni V, Moye S, Navratilova E, Davis P, Ma S-W, Vanderah TW et al..  2013.  Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities.. Bioorg Med Chem Lett. 23(17):4975-8.
2009
Nair P, Yamamoto T, Kulkarni V, Moye S, Navratilova E, Davis P, Largent T, Ma S-W, Yamamura HI, Vanderah T et al..  2009.  Novel bifunctional peptides as opioid agonists and NK-1 antagonists.. Adv Exp Med Biol. 611:537-8.